The 4th international Medtech & Pharma Platform (MPP) conference, held in Basel and co-organized by SFL and Swiss Medtech, attracted delegates and speakers from 11 countries, representing pharma and medtech companies, regulatory agencies, academic organizations, government institutions and service companies.
“Medical products and technologies for cutting-edge solutions”
In line with the 2017 conference theme, the six sessions of the two-day program focused on hot topics related to medical devices, in-vitro diagnostics and combination products. Internationally acknowledged speakers discussed regulatory trends, innovative technologies, the role of design, connectivity in relation to health data, and accessibility of medical products in emerging markets.
Fostering cross-sector contacts and cooperation
Numerous stimulating discussions with table top exhibitors from different sectors, and during the highly rated 1-on-1 partnering meetings, allowed participants to exchange views on innovative technologies and facilitated the creation of lasting connections. The balance of delegates from medtech and pharma companies complemented the cross-sectoral character of the conference fittingly.
The MPP association to engage in European policy work
In her closing speech, Ms. Fürst-Ladani, CEO of SFL, highlighted the future directions of MPP and invited companies active in the field of combined products to become members of the MPP association. In the coming months, the MPP will be setting up working groups concerning the new medical devices and in vitro diagnostics regulations, with focus on European policy work. The group discussions aim to ensure that the interests of key stakeholders and MPP members are conveyed in the soon to be published delegated and implementing acts.
Save the date for the 5th anniversary of the MPP event on 16 – 17 October 2018, to be hosted in Basel.